Filing Details
- Accession Number:
- 0001225208-22-006818
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-10 20:55:03
- Reporting Period:
- 2022-05-08
- Accepted Time:
- 2022-05-10 20:55:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204551 | A Michael Mussallem | One Edwards Way Irvine CA 92614 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-08 | 56,831 | $0.00 | 157,353 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-05-10 | 45,050 | $21.76 | 202,403 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-05-10 | 2,724 | $96.12 | 199,679 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-10 | 4,700 | $93.41 | 194,979 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-10 | 12,028 | $95.39 | 182,951 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-10 | 12,500 | $0.00 | 170,451 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2022-05-10 | 13,098 | $94.54 | 157,353 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-05-10 | 12,500 | $0.00 | 3,406,517 | No | 4 | G | Indirect | By Living Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Indirect | By Living Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Rights | Disposition | 2022-05-08 | 56,831 | $0.00 | 56,831 | $0.00 |
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2022-05-10 | 45,050 | $0.00 | 45,050 | $21.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 48,712 | 2022-05-08 | 2026-05-07 | No | 4 | M | Direct |
| 0 | 2015-06-14 | 2022-05-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 371,711 | Indirect | 401(k) |
Footnotes
- On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.
- This transaction was executed in multiple trades at prices ranging from $95.905 to $96.470. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $92.880 to $93.880. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $94.900 to $95.900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $93.890 to $94.890. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
